EnsoData, a provider of artificial intelligence (AI) solutions to assist with sleep testing, diagnosis, and treatment, and React Health, a sleep and respiratory device manufacturer, announced a strategic collaboration to optimize PAP adherence support for patients with sleep apnea.
EnsoData’s adherence prediction AI will be integrated into React Health’s recently launched React Health Connect platform. This collaboration aims to empower referring physicians and durable medical equipment suppliers with actionable data to provide timely, personalized support to patients who are struggling with therapy adherence.
Further reading: AI Predicts CPAP Adherence Within Weeks of Treatment
“By partnering with EnsoData, we are making another significant investment in our sleep therapy product portfolio,” says Tom Pontzius, president of React Health, in a release. “EnsoData’s predictive analytics will allow our customers to prioritize and focus on the patients that need intervention the most and will ultimately provide a more personalized and positive patient experience.”
Chris Fernandez, chief research officer of Ensodata, adds in a release, “Our PAP compliance AI model has an incredible ability to predict compliance within days of starting treatment. We are excited about the transformative impact our technology can have on the multitude of patients who face challenges in treating their sleep apnea. Our goal is to strengthen the bond between healthcare providers and patients, resulting in improved patient outcomes.”
Photo 145015667 © Wrightstudio | Dreamstime.com
